Metformin: A Deeper Look at How This Diabetes Drug Works

For over 60 years, metformin has been a cornerstone in managing type 2 diabetes, effectively controlling blood sugar levels. However, the precise mechanisms behind its efficacy have remained somewhat elusive – until now. Recent groundbreaking research suggests metformin exerts its effects directly within the brain, opening doors to novel treatment strategies and a broader understanding of its health benefits.

Unveiling the Brain’s Role in Metformin’s Action

Researchers at the Baylor College of Medicine in the US, in a 2025 study, identified a specific brain pathway through which metformin appears to operate, complementing its well-established effects on other bodily systems. “It’s been widely accepted that metformin lowers blood glucose primarily by reducing glucose output in the liver. Other studies have found that it acts through the gut,” explains Makoto Fukuda, a pathophysiologist at Baylor. “We looked into the brain as it is widely recognized as a key regulator of whole-body glucose metabolism. We investigated whether and how the brain contributes to the anti-diabetic effects of metformin.”

Previous work by the same team had pinpointed a protein called Rap1 in the brain, specifically within the ventromedial hypothalamus (VMH), as playing a crucial role in glucose metabolism. Their 2025 study revealed that metformin travels to the VMH, where it effectively ‘switches off’ Rap1, thereby combating type 2 diabetes. Remarkably, mice bred without Rap1 showed no response to metformin, even while responding to other diabetes medications – strong evidence of metformin’s unique brain-based mechanism.

Targeting Specific Neurons for Enhanced Treatment

The research team further identified specific neurons within the VMH that are activated by metformin: SF1 neurons. This discovery paves the way for developing more targeted treatments that directly influence these neurons, potentially maximizing the drug’s effectiveness. “We also investigated which cells in the VMH were involved in mediating metformin’s effects,” says Fukuda. “We found that SF1 neurons are activated when metformin is introduced into the brain, suggesting they’re directly involved in the drug’s action.”

Beyond Diabetes: Metformin’s Potential for Longevity and Brain Health

Metformin’s benefits extend beyond diabetes management. It’s known for its affordability and long-term efficacy, reducing glucose production in the liver and improving insulin sensitivity. Now, with the understanding of its brain activity, the potential for broader applications is becoming increasingly clear.

This discovery aligns with other studies suggesting metformin can slow brain aging and even improve lifespan. A 2025 study involving over 400 postmenopausal women demonstrated that those taking metformin had a 30% lower risk of mortality before age 90 compared to those on sulfonylurea. This highlights metformin’s potential role in mitigating the effects of aging. Science Alert provides further details on this research.

Understanding how metformin impacts the entire body could inform prescribing decisions beyond diabetes and potentially enhance its safety profile. “This discovery changes how we think about metformin,” Fukuda emphasizes. “It’s not just working in the liver or the gut, it’s also acting in the brain.” He also notes that the brain responds to significantly lower concentrations of the drug compared to the liver and intestines.

Potential Side Effects and Considerations

While generally safe, metformin can cause side effects, most commonly gastrointestinal issues like nausea, diarrhea, and abdominal discomfort, affecting up to 75% of users. Individuals with kidney impairment should also exercise caution. However, metformin is increasingly recognized as a gerotherapeutic – a drug capable of slowing down various aging processes, including limiting DNA damage and promoting genes associated with longevity.

The Future of Metformin Research

The research, published in Science Advances, opens exciting avenues for developing new diabetes treatments that specifically target this brain pathway. Researchers also plan to investigate whether the same brain Rap1 signaling is responsible for metformin’s other documented benefits, such as slowing brain aging. This deeper understanding of metformin’s mechanisms promises a future where this versatile drug can be utilized for a wider range of health applications.